Table of Contents Chapter 1 Overview of Point of Care (PoC) Molecular Diagnostics 1.1 Definition of Point of Care (PoC) Molecular Diagnostics in This Report 1.2 Commercial Types of Point of Care (PoC) Molecular Diagnostics 1.2.1 Polymerase Chain Reaction (Real Time PCR) 1.2.2 In Situ Hybridization 1.2.3 Chips and Microarrays 1.2.4 Mass Spectrometry 1.2.5 Sequencing 1.2.6 Isothermal Amplification 1.2.7 Others 1.3 Downstream Application of Point of Care (PoC) Molecular Diagnostics 1.3.1 Hospitals 1.3.2 Diagnostic Laboratories 1.3.3 Research & Academic Laboratories 1.4 Development History of Point of Care (PoC) Molecular Diagnostics 1.5 Market Status and Trend of Point of Care (PoC) Molecular Diagnostics 2013-2023 1.5.1 Global Point of Care (PoC) Molecular Diagnostics Market Status and Trend 2013-2023 1.5.2 Regional Point of Care (PoC) Molecular Diagnostics Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Point of Care (PoC) Molecular Diagnostics 2013-2017 2.2 Production Market of Point of Care (PoC) Molecular Diagnostics by Regions 2.2.1 Production Volume of Point of Care (PoC) Molecular Diagnostics by Regions 2.2.2 Production Value of Point of Care (PoC) Molecular Diagnostics by Regions 2.3 Demand Market of Point of Care (PoC) Molecular Diagnostics by Regions 2.4 Production and Demand Status of Point of Care (PoC) Molecular Diagnostics by Regions 2.4.1 Production and Demand Status of Point of Care (PoC) Molecular Diagnostics by Regions 2013-2017 2.4.2 Import and Export Status of Point of Care (PoC) Molecular Diagnostics by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Point of Care (PoC) Molecular Diagnostics by Types 3.2 Production Value of Point of Care (PoC) Molecular Diagnostics by Types 3.3 Market Forecast of Point of Care (PoC) Molecular Diagnostics by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry 4.2 Market Forecast of Point of Care (PoC) Molecular Diagnostics by Downstream Industry Chapter 5 Market Driving Factor Analysis of Point of Care (PoC) Molecular Diagnostics 5.1 Global Economy Situation and Trend Overview 5.2 Point of Care (PoC) Molecular Diagnostics Downstream Industry Situation and Trend Overview Chapter 6 Point of Care (PoC) Molecular Diagnostics Market Competition Status by Major Manufacturers 6.1 Production Volume of Point of Care (PoC) Molecular Diagnostics by Major Manufacturers 6.2 Production Value of Point of Care (PoC) Molecular Diagnostics by Major Manufacturers 6.3 Basic Information of Point of Care (PoC) Molecular Diagnostics by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Point of Care (PoC) Molecular Diagnostics Major Manufacturer 6.3.2 Employees and Revenue Level of Point of Care (PoC) Molecular Diagnostics Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Point of Care (PoC) Molecular Diagnostics Major Manufacturers Introduction and Market Data 7.1 Bayer Corporation 7.1.1 Company profile 7.1.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.1.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Corporation 7.2 Roche Diagnostics 7.2.1 Company profile 7.2.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.2.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics 7.3 Sysmex Corporation 7.3.1 Company profile 7.3.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.3.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Sysmex Corporation 7.4 Abaxis 7.4.1 Company profile 7.4.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.4.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis 7.5 Abbott Laboratories 7.5.1 Company profile 7.5.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.5.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories 7.6 BioMerieux SA 7.6.1 Company profile 7.6.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.6.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BioMerieux SA 7.7 Bio-Rad Laboratories 7.7.1 Company profile 7.7.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.7.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories 7.8 Danaher Corporation 7.8.1 Company profile 7.8.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.8.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation 7.9 OraSure Technologies 7.9.1 Company profile 7.9.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.9.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of OraSure Technologies Chapter 8 Upstream and Downstream Market Analysis of Point of Care (PoC) Molecular Diagnostics 8.1 Industry Chain of Point of Care (PoC) Molecular Diagnostics 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Point of Care (PoC) Molecular Diagnostics 9.1 Cost Structure Analysis of Point of Care (PoC) Molecular Diagnostics 9.2 Raw Materials Cost Analysis of Point of Care (PoC) Molecular Diagnostics 9.3 Labor Cost Analysis of Point of Care (PoC) Molecular Diagnostics 9.4 Manufacturing Expenses Analysis of Point of Care (PoC) Molecular Diagnostics Chapter 10 Marketing Status Analysis of Point of Care (PoC) Molecular Diagnostics 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Polymerase Chain Reaction (Real Time PCR) Table Advantage and Disadvantage of In Situ Hybridization Table Advantage and Disadvantage of Chips and Microarrays Table Advantage and Disadvantage of Mass Spectrometry Table Advantage and Disadvantage of Sequencing Table Advantage and Disadvantage of Isothermal Amplification Table Advantage and Disadvantage of Others Table Production Volume of Point of Care (PoC) Molecular Diagnostics by Regions 2013-2017 Table Production Value of Point of Care (PoC) Molecular Diagnostics by Regions 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Regions 2013-2017 Table Production and Demand Status of Point of Care (PoC) Molecular Diagnostics in Region One 2013-2017 Table Production and Demand Status of Point of Care (PoC) Molecular Diagnostics in Region Two 2013-2017 Table Production and Demand Status of Point of Care (PoC) Molecular Diagnostics in Region Three 2013-2017 Table Production and Demand Status of Point of Care (PoC) Molecular Diagnostics in Region Four 2013-2017 Table Import Volume of Point of Care (PoC) Molecular Diagnostics by Regions 2013-2017 Table Export Volume of Point of Care (PoC) Molecular Diagnostics by Regions 2013-2017 Table Production Volume of Point of Care (PoC) Molecular Diagnostics by Types 2013-2017 Table Production Value of Point of Care (PoC) Molecular Diagnostics by Types 2013-2017 Table Production Volume Forecast of Point of Care (PoC) Molecular Diagnostics by Types 2018-2023 Table Production Value Forecast of Point of Care (PoC) Molecular Diagnostics by Types 2018-2023 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry 2013-2017 Table Demand Volume Forecast of Point of Care (PoC) Molecular Diagnostics by Downstream Industry 2018-2023 Table Production Volume of Point of Care (PoC) Molecular Diagnostics by Major Manufacturers 2013-2017 Table Production Value of Point of Care (PoC) Molecular Diagnostics by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Point of Care (PoC) Molecular Diagnostics Major Manufacturer Table Employees and Revenue Level of Point of Care (PoC) Molecular Diagnostics Major Manufacturer Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Bayer Corporation Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Bayer Corporation Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Corporation 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Roche Diagnostics Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Roche Diagnostics Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Sysmex Corporation Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Sysmex Corporation Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Sysmex Corporation 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Abaxis Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Abaxis Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Abbott Laboratories Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Abbott Laboratories Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of BioMerieux SA Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of BioMerieux SA Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BioMerieux SA 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Bio-Rad Laboratories Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Bio-Rad Laboratories Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Danaher Corporation Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Danaher Corporation Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of OraSure Technologies Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of OraSure Technologies Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of OraSure Technologies 2013-2017